AVC
LOE Approachingsulfanilamide
NDAVAGINALCREAM
Approved
Jun 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Clinical Trials (5)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Started Sep 2024
274 enrolled
Geographic AtrophyMacular Degeneration
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Started Mar 2023
305 enrolled
Geographic Atrophy
AAVCAGsCD59 for the Treatment of Wet AMD
Started Sep 2018
25 enrolled
Wet Age-related Macular Degeneration
Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
Started Mar 2017
17 enrolled
Dry Age-related Macular Degeneration
Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia
Started Feb 2016
9,845 enrolled
Malaria